Actos

NDC 64764-151 · Takeda Pharmaceuticals America, Inc.

Generic namepioglitazone

Dosage formTABLET

RouteORAL

Active ingredient(s)PIOGLITAZONE HYDROCHLORIDE

Strength15 mg/1

Pharmacologic classPeroxisome Proliferator Receptor alpha Agonist [EPC], Peroxisome Proliferator Receptor gamma Agonist [EPC], Peroxisome Proliferator-activated Receptor alpha Agonists [MoA], Peroxisome Proliferator-activated Receptor gamma Agonists [MoA], Thiazolidinedione [EPC], Thiazolidinediones [CS]

Marketing categoryNDA

Packages

64764-151-02 — 6 CARTON in 1 TRAY (64764-151-02) / 1 BLISTER PACK in 1 CARTON / 7 TABLET in 1 BLISTER PACK

64764-151-04 — 30 TABLET in 1 BOTTLE (64764-151-04)

64764-151-05 — 90 TABLET in 1 BOTTLE (64764-151-05)

64764-151-06 — 500 TABLET in 1 BOTTLE (64764-151-06)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

57237-218 — Pioglitazone Hydrochloride and Metformin Hydrochloride, 57237-219 — Pioglitazone, 57237-220 — Pioglitazone, 57237-221 — Pioglitazone, 60687-391 — Pioglitazone, 60687-905 — Pioglitazone, 62135-804 — PIOGLITAZONE HYDROCHLORIDE, 62135-805 — PIOGLITAZONE HYDROCHLORIDE, 62135-806 — PIOGLITAZONE HYDROCHLORIDE, 64764-123 — alogliptin and pioglitazone, 64764-158 — pioglitazone and metformin hydrochloride, 64764-251 — alogliptin and pioglitazone, 64764-253 — alogliptin and pioglitazone, 64764-254 — alogliptin and pioglitazone, 64764-301 — pioglitazone, 64764-302 — pioglitazone and glimepiride, 64764-304 — pioglitazone and glimepiride, 64764-451 — pioglitazone, 65862-512 — pioglitazone hydrochloride, 65862-513 — pioglitazone hydrochloride, +68 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.